Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients

Maria Guarino,Ilaria Esposito,Giuseppe Portella,Valentina Cossiga,Ilaria Loperto,Raffaella Tortora,Michele Cennamo,Mario Capasso,Daniela Terracciano,Alfonso Galeota Lanza,Sarah Di Somma,Francesco Paolo Picciotto,Filomena Morisco

Clinical Gastroenterology and Hepatology（2022）

引用 21|浏览8

暂无评分

摘要

Three months after vaccination, LT recipients showed humoral response in 75% of cases. Older age, shorter time from transplantation, and use of antimetabolites were factors associated with non-response to vaccination, and LT recipients at risk of non-response to vaccination needed to be kept under close monitoring.

查看译文

关键词

COVID-19,Immunosuppression,Liver Transplantation,SARS-CoV-2 Vaccination

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要